141 related articles for article (PubMed ID: 6867066)
1. Drug discrimination in rats: evidence for amphetamine-like cue state following chronic haloperidol.
Barrett RJ; Steranka LR
Pharmacol Biochem Behav; 1983 Apr; 18(4):611-7. PubMed ID: 6867066
[TBL] [Abstract][Full Text] [Related]
2. Amphetamine-haloperidol discrimination: effects of chronic drug treatment.
Haenlein M; Caul WF; Barrett RJ
Pharmacol Biochem Behav; 1985 Dec; 23(6):949-52. PubMed ID: 4080781
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
Barrett RJ; Caul WF; Stadler JR; Smith RL
Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
[TBL] [Abstract][Full Text] [Related]
4. Characterizing withdrawal in rats following repeated drug administration using an amphetamine-vehicle-haloperidol drug discrimination.
Stadler JR; Caul WF; Barrett RJ
Psychopharmacology (Berl); 1999 Apr; 143(3):219-26. PubMed ID: 10353423
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus properties of substituted amphetamine derivatives.
Corrigall WA; Coen KM; Saouda FM; Robertson JM; Lodge BA
Pharmacol Biochem Behav; 1992 Dec; 43(4):1117-9. PubMed ID: 1475294
[TBL] [Abstract][Full Text] [Related]
6. Environmental modulation of the interoceptive effects of amphetamine in the rat.
Paolone G; Palopoli M; Marrone MC; Nencini P; Badiani A
Behav Brain Res; 2004 Jun; 152(1):149-55. PubMed ID: 15135978
[TBL] [Abstract][Full Text] [Related]
7. Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcement.
Barrett RJ; Caul WF; Huffman EM; Smith RL
Psychopharmacology (Berl); 1994 Jan; 113(3-4):289-96; discussion 297-303. PubMed ID: 7862836
[TBL] [Abstract][Full Text] [Related]
8. Rebound cue state following a single dose of haloperidol.
Caul WF; Jones JR; Schmidt TA; Murphy SM; Barrett RJ
Life Sci; 1991; 49(17):PL119-24. PubMed ID: 1943434
[TBL] [Abstract][Full Text] [Related]
9. Similarities between the stimulus properties of phenylpropanolamine and amphetamine.
Lee F; Stafford I; Hoebel BG
Psychopharmacology (Berl); 1989; 97(3):410-2. PubMed ID: 2497491
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of a low dl-amphetamine dose.
Colpaert FC; Kuyps JJ; Niemegeers CJ; Janssen PA
Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):34-42. PubMed ID: 999400
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat.
Tilson HA; Baker TG; Gylys JA
Psychopharmacologia; 1975 Nov; 44(3):225-8. PubMed ID: 1208758
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine.
Mechanic JA; Wasielewski JA; Carl KL; Holloway FA
Pharmacol Biochem Behav; 2002 Jul; 72(4):767-77. PubMed ID: 12062565
[TBL] [Abstract][Full Text] [Related]
13. Haloperidol-induced supersensitivity to the discrimination of apomorphine.
Schechter MD
Eur J Pharmacol; 1981 Sep; 74(4):343-6. PubMed ID: 7297600
[TBL] [Abstract][Full Text] [Related]
14. Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA).
Baker LE; Virden TB; Miller ME; Sullivan CL
Pharmacol Biochem Behav; 1997 Oct; 58(2):505-16. PubMed ID: 9300612
[TBL] [Abstract][Full Text] [Related]
15. (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats.
Bardo MT; Bevins RA; Klebaur JE; Crooks PA; Dwoskin LP
Pharmacol Biochem Behav; 1997 Dec; 58(4):1083-7. PubMed ID: 9408217
[TBL] [Abstract][Full Text] [Related]
16. Evidence for bidirectional cues as a function of time following treatment with amphetamine: implications for understanding tolerance and withdrawal.
Barrett RJ; Caul WF; Smith RL
Pharmacol Biochem Behav; 2004 Dec; 79(4):761-71. PubMed ID: 15582685
[TBL] [Abstract][Full Text] [Related]
17. Tolerance, withdrawal, and supersensitivity to dopamine mediated cues in a drug-drug discrimination.
Barrett RJ; White DK; Caul WF
Psychopharmacology (Berl); 1992; 109(1-2):63-7. PubMed ID: 1365673
[TBL] [Abstract][Full Text] [Related]
18. The effects of electroconvulsive shock on the discriminative stimulus properties of d-amphetamine and apomorphine: evidence for dopamine receptor alteration subsequent ECS.
White DK; Barrett RJ
Psychopharmacology (Berl); 1981; 73(3):211-4. PubMed ID: 6787638
[TBL] [Abstract][Full Text] [Related]
19. A three-choice haloperidol-saline-cocaine drug discrimination task in rats.
Gauvin DV; Goulden KL; Holloway FA
Pharmacol Biochem Behav; 1994 Sep; 49(1):223-7. PubMed ID: 7816878
[TBL] [Abstract][Full Text] [Related]
20. Rebound responding following a single dose of drug using an amphetamine-vehicle-haloperidol drug discrimination.
Caul WF; Barrett RJ; Huffman EM; Stadler JR
Psychopharmacology (Berl); 1996 Dec; 128(3):274-9. PubMed ID: 8972547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
